Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 127831, 11 pages
http://dx.doi.org/10.1155/2014/127831
Review Article

Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature

1Department of General Surgery, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430077, China
2Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL 32610, USA
3Department of Rehabilitation, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430077, China
4Department of Medicine and Division of Digestion Disease, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430077, China
5Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei 430030, China

Received 25 June 2014; Revised 21 August 2014; Accepted 8 September 2014; Published 14 October 2014

Academic Editor: Chao Hung Hung

Copyright © 2014 Sheng-Li Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sheng-Li Yang, Xiefan Fang, Zao-Zao Huang, et al., “Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature,” Disease Markers, vol. 2014, Article ID 127831, 11 pages, 2014. doi:10.1155/2014/127831